Production (Stage)
NuGen Medical Devices Inc.
NGMD.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 779.20K | 733.00K | 560.00K | 256.40K | 262.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 779.20K | 733.00K | 560.00K | 256.40K | 262.30K |
| Cost of Revenue | 375.10K | 354.30K | 296.60K | 130.10K | 133.20K |
| Gross Profit | 404.10K | 378.60K | 263.20K | 126.20K | 128.90K |
| SG&A Expenses | 3.21M | 3.68M | 4.56M | 4.41M | 5.45M |
| Depreciation & Amortization | 453.60K | 471.60K | 470.80K | 489.90K | 506.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.04M | 4.51M | 5.33M | 5.03M | 6.09M |
| Operating Income | -3.26M | -3.78M | -4.77M | -4.77M | -5.83M |
| Income Before Tax | -1.40M | -3.85M | -6.08M | -5.62M | -6.71M |
| Income Tax Expenses | 7.80K | 5.10K | 26.60K | 19.20K | 24.90K |
| Earnings from Continuing Operations | -1.41 | -3.85 | -6.11 | -5.64 | -6.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.41M | -3.85M | -6.11M | -5.64M | -6.73M |
| EBIT | -3.26M | -3.78M | -4.77M | -4.77M | -5.83M |
| EBITDA | -2.81M | -3.32M | -4.38M | -4.36M | -5.37M |
| EPS Basic | -0.01 | -0.02 | -0.03 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.02 | -0.03 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 879.12M | 857.63M | 837.30M | 804.58M | 752.84M |
| Average Diluted Shares Outstanding | 879.12M | 857.63M | 837.30M | 804.58M | 752.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |